Sort
261,768 grants matching “gene therapy”
SPORE in Soft Tissue Sarcoma
$2,126,449Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2019 · CA
Human Retinal Imaging Biomarkers for FTLD-Tau in Relation to FTLD-TDP and Nonamnestic AD
$2,126,420Benjamin J. Kim · University Of Pennsylvania · RF1 · FY2023 · AG
Rhinovirus Infections and Childhood Asthma
$2,126,340Robert F Lemanske · University Of Wisconsin-Madison · P01 · FY2009 · HL
Extracellular RNA biomarkers of myotonic dystrophy type 1
$2,126,281Thurman M Wheeler · Massachusetts General Hospital · R61 · FY2021 · NS
C9orf72 frontotemporal dementia (FTD) and amyotrophic lateral sclerosis(ALS): using patient cells and CRISPR to reveal therapeutic approaches
$2,126,250Bruce R Conklin · J. David Gladstone Institutes · RF1 · FY2021 · AG
Heterogeneity in Autism Spectrum Disorders: Biological Mechanisms, Trajectories, and Treatment Response
$2,126,237Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2020 · HD
Heterogeneity in Autism Spectrum Disorders: Biological Mechanisms, Trajectories, and Treatment Response
$2,126,237Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2021 · HD
Heterogeneity in Autism Spectrum Disorders: Biological Mechanisms, Trajectories, and Treatment Response
$2,126,237Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2018 · HD
Heterogeneity in Autism Spectrum Disorders: Biological Mechanisms, Trajectories, and Treatment Response
$2,126,237Susan Y Bookheimer · University Of California Los Angeles · P50 · FY2019 · HD
The Molecular Biology of Neurosurgery Systems
$2,126,234Shelley D. Smith · University Of Nebraska Medical Center · P20 · FY2011 · RR
Novel Approaches for the Control of Microbial Pathogens
$2,126,032Joseph F Lutkenhaus · University Of Kansas Medical Center · P20 · FY2007 · RR
TRIP: Targeted Gene Therapy for the Treatment of Heart Failure
$2,125,769Roger J. Hajjar · Icahn School Of Medicine At Mount Sinai · P50 · FY2013 · HL
Targeting Lung Cancer Vulnerabilities
$2,125,682John D Minna · Ut Southwestern Medical Center · P50 · FY2021 · CA
IL-2 Family Cytokines and Receptors-- Mechanisms of Regulation & Action
$2,125,666Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
IL-2 Family Cytokines and their Receptors-- Biology of the IL-21 system
$2,125,666Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system
$2,125,666Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Mechanisms of Familial Pulmonary Fibrosis
$2,125,653Timothy S Blackwell · Vanderbilt University Medical Center · P01 · FY2018 · HL
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$2,125,238Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Role of microbiome in cancer and inflammation
$2,124,656Giorgio Trinchieri · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Targeting Pten - An Upstream, Downstream and Offstream Approach
$2,124,342Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2009 · CA
Gene Therapy for Sickle Cell Disease
$2,124,230Arthur W. Nienhuis · St. Jude Children'S Research Hospital · P01 · FY2006 · HL
Developmental and HyperActive Ras Tumor SPORE
$2,124,182David W. Clapp · Indiana University Indianapolis · U54 · FY2019 · CA
Mechanisms of Familial Pulmonary Fibrosis
$2,124,150Timothy S Blackwell · Vanderbilt University Medical Center · P01 · FY2017 · HL
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies
$2,123,313Pamela J Bjorkman · California Institute Of Technology · P01 · FY2013 · AI
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
$2,122,802Massimo F Loda · Weill Medical Coll Of Cornell Univ · P50 · FY2021 · CA